Accessibility Menu
 
Ocean Biomedical logo

Ocean Biomedical

(OTC) OCEA

Current Price$0.00
Market Cap$23,200
Since IPO (2021)-100%
5 YearN/A
1 Year-100%
1 Month-89%

Ocean Biomedical Financials at a Glance

Market Cap

$23,200

Revenue (TTM)

$0.00

Net Income (TTM)

$30.72M

EPS (TTM)

$-0.91

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

143,909

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

OCEA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ocean Biomedical

Industry

Biotechnology

Employees

7

CEO

M. Michelle Berrey, MD

Headquarters

Providence, RI 02903, US

OCEA Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-4%

Return on Assets

-5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.20K

Shares Outstanding

232.37M

Volume

143.91K

Short Interest

0.00%

Avg. Volume

66.58K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$0.00

EBITDA

$0.00

Operating Cash Flow

$4.18M

Capital Expenditure

$0.00

Free Cash Flow

$4.18M

Cash & ST Invst.

$0.00

Total Debt

$16.30M

Ocean Biomedical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$23.20K

N/A

Market Cap/Employee

$3.31K

N/A

Employees

7

N/A

Net Income

$8.24M

-163.4%

EBITDA

$7.90M

-157.9%

Quarterly Fundamentals

Name
Q1 2025YOY CHG

Net Cash

$9.35M

+5.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$9.35M

-5.1%

Return on Assets

-5.03%

N/A

Return on Invested Capital

-4.35%

N/A

Free Cash Flow

$356.00K

+26.6%

Operating Cash Flow

$356.00K

+26.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRPXVirpax Pharmaceuticals, Inc.
$0.01+1485.71%
CEROCERo Therapeutics Holdings, Inc.
$0.03+4.92%
BCTXWBriaCell Therapeutics Corp.
$0.00-0.00%
VINCVincerx Pharma, Inc.
$0.01-1.17%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.86-0.05%
INTCIntel
$65.27-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.93+0.00%
NVTSNavitas Semiconductor
$18.47+0.20%

Questions About OCEA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.